Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 1-2/2016

01-06-2016

Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods

Authors: Masayuki Nagahashi, Akimitsu Yamada, Hiroshi Miyazaki, Jeremy C. Allegood, Junko Tsuchida, Tomoyoshi Aoyagi, Wei-Ching Huang, Krista P. Terracina, Barbara J. Adams, Omar M. Rashid, Sheldon Milstien, Toshifumi Wakai, Sarah Spiegel, Kazuaki Takabe

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 1-2/2016

Login to get access

Abstract

The tumor microenvironment is a determining factor for cancer biology and progression. Sphingosine-1-phosphate (S1P), produced by sphingosine kinases (SphKs), is a bioactive lipid mediator that regulates processes important for cancer progression. Despite its critical roles, the levels of S1P in interstitial fluid (IF), an important component of the tumor microenvironment, have never previously been measured due to a lack of efficient methods for collecting and quantifying IF. The purpose of this study is to clarify the levels of S1P in the IF from murine mammary glands and its tumors utilizing our novel methods. We developed an improved centrifugation method to collect IF. Sphingolipids in IF, blood, and tissue samples were measured by mass spectrometry. In mice with a deletion of SphK1, but not SphK2, levels of S1P in IF from the mammary glands were greatly attenuated. Levels of S1P in IF from mammary tumors were reduced when tumor growth was suppressed by oral administration of FTY720/fingolimod. Importantly, sphingosine, dihydro-sphingosine, and S1P levels, but not dihydro-S1P, were significantly higher in human breast tumor tissue IF than in the normal breast tissue IF. To our knowledge, this is the first reported S1P IF measurement in murine normal mammary glands and mammary tumors, as well as in human patients with breast cancer. S1P tumor IF measurement illuminates new aspects of the role of S1P in the tumor microenvironment.
Literature
12.
go back to reference Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M et al. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010;285(14):10477–86. doi:10.1074/jbc.M109.064162 . Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, Nagahashi M et al. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010;285(14):10477–86. doi:10.​1074/​jbc.​M109.​064162 .
14.
go back to reference Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107–20. doi:10.1016/j.ccr.2012.11.013.CrossRefPubMed Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107–20. doi:10.​1016/​j.​ccr.​2012.​11.​013.CrossRefPubMed
15.
18.
19.
go back to reference Aukland K. Distribution volumes and macromolecular mobility in rat tail tendon interstitium. Am J Phys. 1991;260(2 Pt 2):H409–19. Aukland K. Distribution volumes and macromolecular mobility in rat tail tendon interstitium. Am J Phys. 1991;260(2 Pt 2):H409–19.
28.
go back to reference Lan T, Bi H, Liu W, Xie X, Xu S, Huang H. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879(7–8):520–6. doi:10.1016/j.jchromb.2011.01.015.CrossRef Lan T, Bi H, Liu W, Xie X, Xu S, Huang H. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2011;879(7–8):520–6. doi:10.​1016/​j.​jchromb.​2011.​01.​015.CrossRef
29.
go back to reference Alberg AJ, Armeson K, Pierce JS, Bielawski J, Bielawska A, Visvanathan K, et al. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomark Prev. 2013;22(8):1374–82. doi:10.1158/1055-9965.epi-12-1424.CrossRef Alberg AJ, Armeson K, Pierce JS, Bielawski J, Bielawska A, Visvanathan K, et al. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomark Prev. 2013;22(8):1374–82. doi:10.​1158/​1055-9965.​epi-12-1424.CrossRef
30.
go back to reference Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 2002;62(5):1410–9.PubMed Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 2002;62(5):1410–9.PubMed
31.
go back to reference Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, et al. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res. 2003;23(4):3183–93.PubMed Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, et al. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res. 2003;23(4):3183–93.PubMed
32.
go back to reference Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883–97. doi:10.1038/nrd3248.CrossRefPubMed Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883–97. doi:10.​1038/​nrd3248.CrossRefPubMed
33.
go back to reference Lim KG, Tonelli F, Li Z, Lu X, Bittman R, Pyne S, et al. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. J Biol Chem. 2011;286(21):18633–40. doi:10.1074/jbc.M111.220756.CrossRefPubMedPubMedCentral Lim KG, Tonelli F, Li Z, Lu X, Bittman R, Pyne S, et al. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. J Biol Chem. 2011;286(21):18633–40. doi:10.​1074/​jbc.​M111.​220756.CrossRefPubMedPubMedCentral
34.
go back to reference Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, et al. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal. 2010;22(10):1536–42. doi:10.1016/j.cellsig.2010.05.022.CrossRefPubMedPubMedCentral Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, et al. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal. 2010;22(10):1536–42. doi:10.​1016/​j.​cellsig.​2010.​05.​022.CrossRefPubMedPubMedCentral
35.
go back to reference Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol. 2005;64(8):695–705.CrossRefPubMed Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol. 2005;64(8):695–705.CrossRefPubMed
36.
go back to reference Ruckhaberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2008;112(1):41–52. doi:10.1007/s10549-007-9836-9.CrossRefPubMed Ruckhaberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2008;112(1):41–52. doi:10.​1007/​s10549-007-9836-9.CrossRefPubMed
38.
go back to reference Liu SQ, Su YJ, Qin MB, Mao YB, Huang JA, Tang GD. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Int J Oncol. 2013;42(2):617–26. doi:10.3892/ijo.2012.1733.PubMed Liu SQ, Su YJ, Qin MB, Mao YB, Huang JA, Tang GD. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Int J Oncol. 2013;42(2):617–26. doi:10.​3892/​ijo.​2012.​1733.PubMed
40.
go back to reference Ponnusamy S, Selvam SP, Mehrotra S, Kawamori T, Snider AJ, Obeid LM, et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol Med. 2012;4(8):761–75. doi:10.1002/emmm.201200244.CrossRefPubMedPubMedCentral Ponnusamy S, Selvam SP, Mehrotra S, Kawamori T, Snider AJ, Obeid LM, et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol Med. 2012;4(8):761–75. doi:10.​1002/​emmm.​201200244.CrossRefPubMedPubMedCentral
Metadata
Title
Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods
Authors
Masayuki Nagahashi
Akimitsu Yamada
Hiroshi Miyazaki
Jeremy C. Allegood
Junko Tsuchida
Tomoyoshi Aoyagi
Wei-Ching Huang
Krista P. Terracina
Barbara J. Adams
Omar M. Rashid
Sheldon Milstien
Toshifumi Wakai
Sarah Spiegel
Kazuaki Takabe
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 1-2/2016
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-016-9354-7

Other articles of this Issue 1-2/2016

Journal of Mammary Gland Biology and Neoplasia 1-2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine